We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Microwave Radiation Can Kill Breast Cancer Cells

By HospiMedica staff writers
Posted on 03 Jan 2001
In a phase I clinical trial, researchers found that one to three weeks following a single treatment by a new microwave radiation system, advanced breast cancer tumors typically were reduced in size or destroyed by about 50% in eight out of 10 patients. More...
Phase II clinical trials will now be conducted.

In the procedure, two needle probes are used to sense and measure parameters during treatment. The focused microwave radiation does not heat the skin but heats the cancer cells to about 1150 F and kills them. Breast cancer cells have a high water content, around 80%, while healthy breast tissue contains only 20-60%. The new system has the potential to reduce or eliminate the use of conventional radiation. In the phase II trials, more than 100 women will receive microwave thermotherapy to treat cancer cells. The microwave technology has been licensed to Celsion Corp. (Columbia, MD, USA) by the Massachusetts Institute of Technology (Cambridge, MA, USA).

The new technique was invented by Alan J. Fenn, a senior staff member of MIT's Air Defense Technology Division, based on research he had conducted on radar anti-jamming technology to detect missiles from space-borne satellites. "This is an out-patient procedure,” said Dr. Fenn. "Patients treated in the phase I trial went home with only one or two tiny band aids.”



Related Links:
Celsion

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.